3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Multiple Myeloma
235
Precursor Cell Lymphoblastic Leukemia-Lymphoma
69
Recurrence
36
Burkitt Lymphoma
34
Leukemia
32
Lymphoma
30
Neoplasms, Plasma Cell
22
Lymphoma, Non-Hodgkin
19
Immunoglobulin Light-chain Amyloidosis
18
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Lymphoma, Mantle-Cell
16
Neoplasms
15
Nausea
15
Lymphoma, Large B-Cell, Diffuse
15
Vomiting
14
Hodgkin Disease
13
Breast Neoplasms
12
Waldenstrom Macroglobulinemia
11
Leukemia, Biphenotypic, Acute
11
Lymphoma, Follicular
10
Lymphoma, B-Cell, Marginal Zone
10
Amyloidosis
10
Lung Neoplasms
9
Smoldering Multiple Myeloma
8
Prostatic Neoplasms
8
Neoplasm Metastasis
8
Leukemia, Myeloid, Acute
8
Hematologic Neoplasms
7
Blast Crisis
7
Lymphoma, T-Cell, Cutaneous
6
Interventions
alvimopan
5
Irinotecan
4
Oxaliplatin
3
Capecitabine
3
Bevacizumab
3
Leucovorin
2
Fluorouracil
2
Cyclophosphamide
2
Cetuximab
2
Aspirin
2
repotrectinib
1
pralsetinib
1
pembrolizumab
1
napabucasin
1
guadecitabine
1
encorafenib
1
alectinib
1
Ursodeoxycholic Acid
1
Surveys and Questionnaires
1
Pemetrexed
1
Oviposition
1
Ocoxin
1
Levoleucovorin
1
KRN-330
1
Folfox protocol
1
Exercise
1
Drug Therapy
1
Drainage
1
Chemoradiotherapy
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Intestinal Diseases
×
Calcium Dobesilate
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts